Voluntary Antibiotic Recall Initiated

Article

Three lots of ertapenem, (Invanz) 1g (0803930, 0803940, and 0803950), a Merck antibiotic that is indicated for the treatment of patients with moderate to severe infections, were recalled because of two incidents of broken glass found in the reconstituted solution for injection [more].

Three lots of ertapenem, (Invanz) 1g (0803930, 0803940, and 0803950), a Merck antibiotic that is indicated for the treatment of patients with moderate to severe infections, were recalled because of two incidents of broken glass found in the reconstituted solution for injection. Healthcare professionals are advised to immediately stop dispensing all products from the three lots specified above. All lots have an expiration date of October 2008, and no other lots were affected by this recall. Medical questions about the recall can be directed to Merck’s national service center at 800–672–6372.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Recent Videos
John Browning, MD, provides practical skincare reminders ahead of summer season
Potential downstream benefits of RSV preventive measures, with Octavio Ramilo, MD
Discussing phase 3 data of Panzyga for PANS, with Michael Daines, MD
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD
© 2025 MJH Life Sciences

All rights reserved.